• Profile
Close

The effect of increasing dialysate magnesium on serum calcification propensity in subjects with end stage kidney disease: A randomized, controlled clinical trial

Clinical Journal of the American Society of Nephrology Aug 31, 2018

Bressendorff I, et al. - Researchers gauged if increasing serum magnesium increases serum calcification propensity in subjects with end-stage kidney disease (ESKD). As per data, in subjects undergoing maintenance hemodialysis, serum calcification propensity is increased with increasing dialysate magnesium. At baseline, serum calcification propensity was 233±81 minutes (mean±SD) and at follow-up, it was 229±93 minutes in the standard dialysate magnesium group, whereas serum calcification propensity in the high dialysate magnesium group was 247±69 minutes at baseline and 302±66 minutes at follow-up.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay